SERMs: all 411 studies that test it

Page 2 of 5. Open to participants first (37), then studies with results posted, then the rest; newest registration first within each.

• Assessment of Multiple Intrauterine Gestations From Ovarian StimulationCompletedNCT01044862Phase 3Results posted
• Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer PatientsCompletedNCT01027416Not applicableResults posted
• Traditional Clomiphene Citrate Administration vs. Stair-step ApproachCompletedNCT01008319Phase 3Results posted
• Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast CancerCompletedNCT00999921Phase 4Results posted
• 4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in SituCompletedNCT00952731Phase 2Results posted
• Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal OsteoporosisCompletedNCT00808132Phase 3Results posted
• Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving TamoxifenCompletedNCT00764322Phase 2Results posted
• Nutritional Supplements and Hormonal Manipulations for Breast Cancer PreventionCompletedNCT00723398Not applicableResults posted
• Pregnancy in Polycystic Ovary Syndrome IICompletedNCT00719186Phase 3Results posted
• Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy TreatmentCompletedNCT00710970Phase 2Results posted
• To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical TestosteroneCompletedNCT00706719Phase 2Results posted
• Cognition in the Study of Tamoxifen and RaloxifeneCompletedNCT00687102Phase 3Results posted
• Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02CompletedNCT00659373Phase 3Results posted
• Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral DensityCompletedNCT00431444Phase 4Results posted
• Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian SyndromeCompletedNCT00427700Phase 3Results posted
• Raloxifene for Women With Alzheimer's DiseaseCompletedNCT00368459Phase 2Results posted
• Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic AcidCompletedNCT00295646Phase 3Results posted
• Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast CancerCompletedNCT00293540Phase 3Results posted
• Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in SituCompletedNCT00290745Phase 1/2Results posted
• Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in SituTerminatedNCT00290654Phase 2Results posted
• Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal WomenCompletedNCT00242710Phase 3Results posted
• Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory DysfunctionCompletedNCT00213148Phase 2Results posted
• Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal WomenCompletedNCT00205777Phase 3Results posted
• Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast CancerCompletedNCT00201851Phase 3Results posted
• A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)TerminatedNCT00183963Phase 2Results posted
• Tamoxifen and Bortezomib to Treat Recurrent Brain TumorsCompletedNCT00108069Phase 2Results posted
• Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)CompletedNCT00106691Phase 3Results posted
• Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In SituCompletedNCT00072462Phase 3Results posted
• Sulindac and Tamoxifen in Treating Patients With Desmoid TumorCompletedNCT00068419Phase 2Results posted
• Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast CancerCompletedNCT00066690Phase 3Results posted
• Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT00041080Phase 3Results posted
• Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By ExemestaneCompletedNCT00036270Phase 3Results posted
• Raloxifene and Rimostil for Perimenopause-Related DepressionCompletedNCT00030147Phase 4Results posted
• Clomiphene Citrate Alone Versus Clomiphene Plus Metformin as First Line Approach for the Treatment of Anovulation in Infertile Patients With Polycystic Ovary SyndromeCompletedNCT07872501Not applicable
• SHORTened Duration of TAMoxifenActive, not recruitingNCT07806630Phase 2
• Letrozole vs. Clomiphene Citrate Plus Tamoxifen for Ovulation Induction and Pregnancy Outcomes.Active, not recruitingNCT07616973Phase 3
• Comparison of Clomid and Lezra With Lezra for Ovulation Induction in Clomid Resistant PCOS CaseCompletedNCT06813118Phase 1
• Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialSuspendedNCT06671912Phase 3
• One-shot Ovarian Stimulation Protocol (One-shot)CompletedNCT06635538Not applicable
• Clomiphene Citrate in Infertile Men With Idiopathic OligoasthenozoospermiaCompletedNCT06564961Phase 3
• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceActive, not recruitingNCT06492616Phase 3
• Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.Active, not recruitingNCT06449027Phase 3
• Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTionCompletedNCT06033092Phase 2
• Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast CancerActive, not recruitingNCT05826964Phase 2
• Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast CancerActive, not recruitingNCT05780567Phase 3
• CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian PopulationStatus unknownNCT05501158Not applicable
• Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast CancerActive, not recruitingNCT05463601Phase 2
• Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With OsteopeniaCompletedNCT05386784Phase 4
• Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian CancerActive, not recruitingNCT05156892Phase 1
• Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast CancerCompletedNCT05150652Phase 2
• Therapeutic Dose Monitoring (TDM) of TamoxifenStatus unknownNCT05133674Phase 2
• Pharmacokinetic Evaluation of Serum Testosterone Concentrations After Administration of Clomiphene CitrateWithdrawnNCT05096169Phase 2
• Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.Status unknownNCT05016349Phase 3
• Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer PatientsActive, not recruitingNCT04997941Phase 2
• Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376Active, not recruitingNCT04961632Phase 1
• Tamoxifen Versus Estradiol for Unscheduled Bleeding in Etonogestrel Implant Users, a Randomized Pilot TrialWithdrawnNCT04933240Phase 4
• Tamoxifen Therapy for Myotubular MyopathyTerminatedNCT04915846Phase 1/2
• Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood BiomarkersCompletedNCT04821375Early Phase 1
• Phase IIB Trial of Bazedoxifene Plus Conjugated EstrogensActive, not recruitingNCT04821141Phase 2
• Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic AdenocarcinomaStatus unknownNCT04812808Not applicable
• Selective Estrogen Modulation and Melatonin in Early COVID-19WithdrawnNCT04531748Phase 2
• Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome CoronavirusStatus unknownNCT04389580Phase 2
• BMI Effect on the Response to Ovulation Induction in Letrozole vs ClomidStatus unknownNCT04331197Phase 4
• Thin Endometrium Undergoing Frozen-thawed Embryo TransferStatus unknownNCT04292886Not applicable
• Incremental Clomiphene Citrate Doses in Successive Cycles and FSH, LH and Steroid Hormone LevelsCompletedNCT04210765Phase 4
• A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent GlioblastomaWithdrawnNCT04200066Phase 1
• Added Value of N Acetyle Cysteine to Clomiphene Citrate in PCOCompletedNCT04170439Not applicable
• Mild Stimulation Protocol Using Clomiphene Citrate for Women With PCOS Undergoing in Vitro FertilizationActive, not recruitingNCT04157725Phase 4
• Advancing Postmenopausal Preventive TherapyActive, not recruitingNCT04103476Phase 2
• Can we Use Estrogen-containing Therapy to Improve Pain in Women After Menopause With Hand Osteoarthritis?CompletedNCT04036929Not applicable
• Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One BreastActive, not recruitingNCT04009044Phase 2
• Bazedoxifene Acetate as a Remyelinating Agent in Multiple SclerosisCompletedNCT04002934Phase 2
• Pulsatile Gonadotropin-releasing Hormone for Infertility in Non-obese Patients With Polycystic Ovary SyndromeStatus unknownNCT03989024Phase 4
• Impact of Estrogen + Estradiol Receptor Alpha Modulator Therapy on Oxidative Stress in Post-menopausal Women With and Without Sleep ApneaStatus unknownNCT03981341Phase 3
• Limited Adjuvant Endocrine Therapy for Low Risk Breast CancerActive, not recruitingNCT03917082Phase 2
• Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 MutationStatus unknownNCT03879174Phase 2
• Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive ExpressionCompletedNCT03870399Phase 2
• Comparative Antiresorptive Efficacy Discontinuation of DenosumabActive, not recruitingNCT03623633Phase 4
• Interest of Clomiphene Citrate in Patients With Non-obstructive Azoospermia on the Quantity of Sperm CellsWithdrawnNCT03615547Phase 3
• Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in WomenCompletedNCT03418831Phase 4
• Double Ovarian Stimulation as Accumulation Strategy for Older Infertile Patients With Suboptimal Ovarian ResponseStatus unknownNCT03400722Phase 4
• Effect of Vitamin D Supplement in Induction of Ovulation in Overweight Women With Polycystic Ovary SyndromeStatus unknownNCT03396380Phase 3
• Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast CancerStatus unknownNCT03373708Phase 2/3
• Tamoxifen in Duchenne Muscular DystrophyCompletedNCT03354039Phase 3
• Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOSStatus unknownNCT03316469Not applicable
• Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast CancerWithdrawnNCT03238703Phase 4
• HDDO-1614 Intervention TrialCompletedNCT03234244Phase 1
• The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast CancersStatus unknownNCT03211572Phase 2
• Clomiphene Citrate Stair-Step ProtocolStatus unknownNCT03178500Not applicable
• Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing SurgeryWithdrawnNCT03147196Phase 2
• Treatment With Tamoxifen in Cryptococcal MeningitisCompletedNCT03112031Phase 2
• The Effect of Tamoxifen on Clinical Outcome in Women With Thin Endometrium Undergoing Frozen Thawed Cycle.Status unknownNCT03060304Phase 4
• Raloxifene Augmentation in Patients With a Schizophrenia Spectrum DisorderCompletedNCT03043820Phase 3
• Administration of Clomiphene: Short and Long Term Metabolism in an Anti-Doping SettingCompletedNCT03028532Phase 1
• Osteoporosis Treatment in Post-menopausal WomenStatus unknownNCT03006003Phase 4
• A Phase 1 Drug Drug Interaction Clinical Trial of C1-R215 and C2-R215 in Healthy Male VolunteersStatus unknownNCT03005340Phase 1
• Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer PatientsCompletedNCT02995772Phase 3
• Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid ArthritisCompletedNCT02982083Not applicable
• Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.CompletedNCT02866955Phase 2
• Treatment Effect of Tamoxifen on Patients With DMDCompletedNCT02835079Phase 1

← SERMs overview